Active Ingredient: PALONOSETRON HYDROCHLORIDE
Proprietary Name: PALONOSETRON HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A090713
Product Number: 001
Approval Date: Mar 23, 2018
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: PALONOSETRON HYDROCHLORIDE
Proprietary Name: PALONOSETRON HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090713
Product Number: 002
Approval Date: Mar 23, 2018
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:
Discontinued
Patent and Exclusivity Information